… (EGFR), such as erlotinib (Tarceva) and gefitinib (Iressa), have shown … randomized controlled
trial showing a survival benefit compared with placebo, erlotinib gained US Food and Drug …

… Gefitinib was proven to be the better choice for advanced NSCLC, with equal antitumor …
AEs compared with erlotinib. Further large-scale, well-designed randomized controlled trials are …

… abstracts of randomized controlled trials (phase II or phase III) comparing gefitinib or erlotinib,
alone … , or comparing different doses or schedules of gefitinib or erlotinib. Data on symptom …

… This study aimed to investigate the noninferiority of gefitinib compared with erlotinib. The
primary … On the basis of these factors, we established our trial as a noninferiority clinical trial. …

… database, the Cochrane Central Register of Controlled Trials (CENTRAL), the China …
following terms: gefitinib, non-small cell lung cancer, NSCLC, and randomized controlled trial. The …

… study was a three-arm randomized open-label phase II study … and gefitinib to either pemetrexed
plus carboplatin or gefitinib alone … -2 study, intercalating chemotherapy with erlotinib.23 …

… Several meta-analysis of randomized clinical trials have demonstrated that platinum-based
combination chemotherapy is able to induce a modest but significant survival advantage …

… clinical trials comparing the success rate of gefitinib, erlotinib and icotinib have been reported.
In the current study, … The quality of randomized controlled trials from the Cochrane network …

… Clinical studies have gradually demonstrated that activating … Gefitinib and erlotinib, both
regarded as first-generation EGFR… and dacomitinib improved PFS compared to gefitinib [58,59]; …

… The randomisation sequence was generated by an independent team from the trial sponsor
with a validated computer system (clinical trial supply system). This team was not involved in …